RU2020101969A3 - - Google Patents

Download PDF

Info

Publication number
RU2020101969A3
RU2020101969A3 RU2020101969A RU2020101969A RU2020101969A3 RU 2020101969 A3 RU2020101969 A3 RU 2020101969A3 RU 2020101969 A RU2020101969 A RU 2020101969A RU 2020101969 A RU2020101969 A RU 2020101969A RU 2020101969 A3 RU2020101969 A3 RU 2020101969A3
Authority
RU
Russia
Application number
RU2020101969A
Other versions
RU2770041C2 (ru
RU2020101969A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2020101969A publication Critical patent/RU2020101969A/ru
Publication of RU2020101969A3 publication Critical patent/RU2020101969A3/ru
Application granted granted Critical
Publication of RU2770041C2 publication Critical patent/RU2770041C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2020101969A 2017-06-21 2018-06-19 Композиция фуразидина в форме суспензии и способ ее получения RU2770041C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL421967A PL236891B1 (pl) 2017-06-21 2017-06-21 Płynna forma podawania furazydyny oraz sposób jej otrzymywania
PLP.421967 2017-06-21
PCT/PL2018/050026 WO2018236236A1 (en) 2017-06-21 2018-06-19 FURAZIDINE COMPOSITION IN SUSPENSION FORM AND PREPARATION METHOD THEREOF

Publications (3)

Publication Number Publication Date
RU2020101969A RU2020101969A (ru) 2021-07-21
RU2020101969A3 true RU2020101969A3 (ru) 2021-09-20
RU2770041C2 RU2770041C2 (ru) 2022-04-14

Family

ID=64737767

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2020101969A RU2770041C2 (ru) 2017-06-21 2018-06-19 Композиция фуразидина в форме суспензии и способ ее получения

Country Status (5)

Country Link
EP (1) EP3641729A4 (ru)
PL (1) PL236891B1 (ru)
RU (1) RU2770041C2 (ru)
UA (1) UA126867C2 (ru)
WO (1) WO2018236236A1 (ru)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1782587A1 (en) * 1989-03-10 1992-12-23 Lvovskij G Med Inst Composition for treating parodontitis
RU2103997C1 (ru) * 1995-04-19 1998-02-10 Акционерное общество закрытого типа "Гекта" Лекарственное средство для лечения заболеваний животных микробной этиологии, способ лечения желудочно-кишечных заболеваний животных микробной этиологии и способы лечения гинекологических заболеваний коров микробной этиологии
US6521270B1 (en) * 2001-06-11 2003-02-18 The Procter & Gamble Company Compositions comprising nitrofurantoin and uva ursi
RU2583945C1 (ru) * 2015-05-13 2016-05-10 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) Средство для местного лечения красного плоского лишая слизистой оболочки полости рта и способ лечения красного плоского лишая слизистой оболочки полости рта
PL234271B1 (pl) * 2016-10-10 2020-01-31 Centrum Badawczo Rozwojowe Novasome Spolka Z Ograniczona Odpowiedzialnoscia Doustna kompozycja farmaceutyczna zawierająca furazydynę w postaci zawiesiny oraz sposoby jej wytwarzania
EP3522929A2 (en) * 2016-10-10 2019-08-14 Przedsiebiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A. New furazidin compositions and methods of their manufacture

Also Published As

Publication number Publication date
PL421967A1 (pl) 2019-01-02
EP3641729A1 (en) 2020-04-29
RU2770041C2 (ru) 2022-04-14
PL236891B1 (pl) 2021-02-22
RU2020101969A (ru) 2021-07-21
UA126867C2 (uk) 2023-02-15
WO2018236236A1 (en) 2018-12-27
EP3641729A4 (en) 2021-03-24

Similar Documents

Publication Publication Date Title
BR122021024397A2 (ru)
BR122021023687A2 (ru)
BR122022025811B8 (ru)
BR122021000189A2 (ru)
BR112019008823A2 (ru)
BR112020006084A8 (ru)
BR122021014832A2 (ru)
BR202018014992U2 (ru)
RU2020101969A3 (ru)
BR112020008820A2 (ru)
BR202017025154U2 (ru)
BR102017023327A2 (ru)
BR202017021228U2 (ru)
BR202017020981U2 (ru)
BE2017C035I2 (ru)
BR202017017068U2 (ru)
BR202017016984U2 (ru)
BR202017016924U2 (ru)
BR102017015495A2 (ru)
BR102017015250A2 (ru)
BR102017014430A2 (ru)
BR202017012548U2 (ru)
BR102017003115A2 (ru)
BR202017002826U2 (ru)
CN303991467S (ru)

Legal Events

Date Code Title Description
HE9A Changing address for correspondence with an applicant